date,title,content,company
"  January 25, 2023 / 10:22 AM IST  ","Hindenburg says holds short positions in India's Adani, flags risks","Short-seller Hindenburg Research said on Wednesday it holds short positions in India's Adani Group companies through U.S.-traded bonds and non-Indian-traded derivative instruments.The seven listed companies of the Adani group, which is controlled by world's third richest man Gautam Adani, have an 85% downside on a fundamental basis due to sky-high valuations, Hindenburg said in the report.To catch all the latest updates from around the world, follow moneycontrol's LIVE blog here""Key listed Adani companies have also taken on substantial debt, including pledging shares of their inflated stock for loans, putting the entire group on precarious financial footing,"" Hindenburg said.An Adani spokesperson did not immediately respond to Reuters request for comment on the report. The company has repeatedly dismissed debt concerns.Adani Chief Financial Officer Jugeshinder Singh said on Jan. 21 ""Nobody has raised debt concerns to us. No single investor has."" Adani Enterprises, the flagship company of ports-to-energy conglomerate Adani Group, has said it will raise $2.5 billion in India's largest follow-on public offering due this Friday.Also read: Truck operators say Adani Cement’s ask is unviable; ACC dealers hurt by supply disruptions Shares of Adani Enterprises surged 125% in 2022, while other group companies, including power and gas units, rose over 100%.Adani Group's total gross debt in the financial year ending March 31, 2022, rose 40% to 2.2 trillion rupees. CreditSights, part of the Fitch Group, described the group last September as ""overleveraged"" and said it had ""concerns"" over its debt.While the report later corrected some calculation errors, CreditSights said it maintained concerns over leverage.",Adani Enterprises Ltd.
"  January 25, 2023 / 11:00 PM IST  ","Bajaj Auto Standalone December 2022 Net Sales at Rs 9,315.14 crore, up 3.25% Y-o-Y","Net Sales at Rs 9,315.14 crore in December 2022 up 3.25% from Rs. 9,021.65 crore in December 2021.Quarterly Net Profit at Rs. 1,491.42 crore in December 2022 up 22.83% from Rs. 1,214.19 crore in December 2021.EBITDA stands at Rs. 2,045.93 crore in December 2022 up 24.38% from Rs. 1,644.90 crore in December 2021.Bajaj Auto EPS has increased to Rs. 52.70 in December 2022 from Rs. 42.00 in December 2021.Bajaj Auto shares closed at 3,686.50 on January 24, 2023 (NSE) and has given -8.32% returns over the last 6 months and 6.27% over the last 12 months.",Bajaj Auto Ltd.
"  January 25, 2023 / 04:10 PM IST  ","Bajaj Auto Q3 net profit zooms 23% to Rs 1,491 crore, beats estimates","Two-wheeler major Bajaj Auto on January 25 reported a standalone net profit of Rs 1,491 crore for the quarter ended December 2022, clocking a 23 percent rise over Rs 1,214 crore a year ago.Revenue from operations came in at Rs 9,315 crore, increasing 3 percent from Rs 9,022 crore in the corresponding quarter last year, the company said in an exchange filing.In an analyst poll, revenue estimates for the quarter were at Rs 8,998.50 crore and net profit at Rs 1,379 crore. Both profit and revenue were better than estimates.ALSO READ: Bajaj Auto sales fall 22% to 2,81,486 units in DecemberThe company said revenue growth was driven by robust double-digit growth in the domestic business, which offset the drop in exports arising from challenging market conditions. Overall, spares revenue came in at an all-time high.At Rs 1,777 crore, EBITDA was the highest ever, surpassing the record set in the previous quarter. The strong growth of 29 percent year on year (YoY), was underpinned by margin expansion of 390 basis points YoY to 19.1 percent. Margin improvement was led by judicious pricing, better dollar realisation and richer product mix.On domestic motorcycles, industry festive demand, particularly in the top end commuter/sports segment, was buoyant and the company said it outperformed with strong growth in the segment.ALSO READ: KTM boss says scope of electric mobility 'highly overrated'On exports, macro-economic challenges continue to subdue industry volumes across overseas geographies, said Bajaj Auto.""While the company continues to navigate this situation through decisive actions, market share remains stable and the resilient performance in ASEAN is alleviating in part, the drop in volumes across other regions,"" it said.Commercial vehicles maintained their path of recovery to pre-covid levels -- now at -75 percent - as the quarter saw strong growth with stepped up volumes and market share hitting an all-time high across segments, Bajaj Auto said.",Bajaj Auto Ltd.
"  January 25, 2023 / 11:07 PM IST  ","Cipla Consolidated December 2022 Net Sales at Rs 5,810.09 crore, up 6.05% Y-o-Y",,Cipla Ltd.
"  January 25, 2023 / 10:39 PM IST  ","Cipla Standalone December 2022 Net Sales at Rs 3,899.45 crore, down 1.4% Y-o-Y","Net Sales at Rs 3,899.45 crore in December 2022 down 1.4% from Rs. 3,954.79 crore in December 2021.Quarterly Net Profit at Rs. 678.52 crore in December 2022 down 7.16% from Rs. 730.83 crore in December 2021.EBITDA stands at Rs. 1,065.23 crore in December 2022 down 4.29% from Rs. 1,112.98 crore in December 2021.Cipla EPS has decreased to Rs. 8.41 in December 2022 from Rs. 9.06 in December 2021.Cipla shares closed at 1,062.15 on January 24, 2023 (NSE) and has given 10.66% returns over the last 6 months and 17.28% over the last 12 months.",Cipla Ltd.
"  January 25, 2023 / 10:08 AM IST  ",Cipla Q3 preview | Consolidated net profit likely to rise 22% YoY,"Drugmaker Cipla Limited is expected to report a higher net profit on a year-on-year (Y-o-Y) basis for the quarter ended December 2022 as it might benefit from higher sales in the US market.Cipla, which will unveil its financial results for the fiscal third quarter on January 25, may see its consolidated  net profit rise 21.9 percent YoY and 10.6 percent Quarter-on-Quarter (QoQ) to Rs 888.4 crore, according to the average estimate of securities firms polled by Moneycontrol.Ahead of results, the stock is trading lower at Rs 1056.55 per share, down by 0.5 percent. On January 24, it closed flat at Rs 1,062.15 apiece.Its India business is expected to have grown at mid-single digits in what is a seasonally weak quarter, according to analysts at BNP Paribas.US sales likely grew at low single digits QoQ to reach $185 million, led by Cipla’s generic version of  Bristol Myers Squibb’s Revlimid,  a prescription drug indicated for several hematological malignancies in adults with multiple myeloma.ICICI Securities projects Cipla’s India business to have grown 4 percent YoY on a higher base while projecting US sales to reach $176 million.It expects sales in SAGA, which includes South Africa, Sub-Saharan Africa and Cipla Global Access, to decline 2.8 percent YoY.Kotak Securities pegs domestic sales to have grown at a more optimistic yearly growth rate of 9 percent and US sales at 6 percent YoY to $190 million, led by market share gains of key products like the Albuterol inhaler, Lanreotide injection and Brovana inhalation solution.Kotak Securities predicts marginally higher sales of the generic version of Revlimid at $25 million.“We expect Cipla's gross margin to stay largely flat sequentially at 62.8 percent. After factoring in slightly higher R&D (5.9 percent of sales), we expect 90 bps (basis points) QoQ improvement in EBITDA margin to 23.3 percent,” Kotak Securities added.One basis point is one-hundredth of a percentage point.“We continue to maintain that the company's FY2023 EBITDA margin guidance of 21-22% is conservative.”EBITDA is short for Earnings Before Interest, Tax, Depreciation and Amortisation.ICICI Securities expects the EBITDA margin to improve YoY led by high-margin Revlimid.Overall, revenue and EBITDA are expected to grow 10.2 percent and 17 percent YoY, while expanding 3.6 percent and 8.3 percent sequentially, respectively, according to the Moneycontrol Poll.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Cipla Ltd.
"  January 25, 2023 / 10:28 AM IST  ",Colgate-Palmolive India: Performance continues to remain sub par,"                        Highlights

	Decline in volume and market share
	Gross margin witnesses sequential recovery
	Increase in investment behind advertisement and publicity
	Remain neutral, despite attractive valuations

The Q3FY23 results for Colgate-Palmolive India (CPIL; CMP: Rs 1,460; Market capitalisation: Rs 39,695 crore) were below expectations.

CPIL continued with its focus on key strategic pillars:  building an oral-care habit in India, driving innovation through science-led products and premiumisation.

December 2022 quarter results

Domestic sales growth was at 3.2 percent year on year (YoY). While we expect volume decline in mid-single digits,...
                    ",Colgate Palmolive (India) Ltd.
"  January 25, 2023 / 11:01 PM IST  ","DLF Standalone December 2022 Net Sales at Rs 925.31 crore, down 12.41% Y-o-Y","Net Sales at Rs 925.31 crore in December 2022 down 12.41% from Rs. 1,056.37 crore in December 2021.Quarterly Net Profit at Rs. 294.86 crore in December 2022 up 107.55% from Rs. 142.07 crore in December 2021.EBITDA stands at Rs. 506.17 crore in December 2022 down 6.98% from Rs. 544.17 crore in December 2021.DLF EPS has increased to Rs. 1.19 in December 2022 from Rs. 0.57 in December 2021.DLF shares closed at 364.90 on January 24, 2023 (NSE) and has given 2.11% returns over the last 6 months and -4.04% over the last 12 months.",DLF Ltd.
"  January 25, 2023 / 10:39 PM IST  ","Dixon Technolog Standalone December 2022 Net Sales at Rs 1,532.81 crore, down 26.64% Y-o-Y","Net Sales at Rs 1,532.81 crore in December 2022 down 26.64% from Rs. 2,089.51 crore in December 2021.Quarterly Net Profit at Rs. 48.78 crore in December 2022 up 38.07% from Rs. 35.33 crore in December 2021.EBITDA stands at Rs. 88.61 crore in December 2022 up 28.61% from Rs. 68.90 crore in December 2021.Dixon Technolog EPS has increased to Rs. 8.22 in December 2022 from Rs. 6.02 in December 2021.Dixon Technolog shares closed at 3,477.00 on January 24, 2023 (NSE) and has given -7.63% returns over the last 6 months and -23.62% over the last 12 months.",Dixon Technologies (India) Ltd.
"  January 25, 2023 / 11:01 PM IST  ","Dr Reddys Labs Standalone December 2022 Net Sales at Rs 3,897.60 crore, up 12.01% Y-o-Y","Net Sales at Rs 3,897.60 crore in December 2022 up 12.01% from Rs. 3,479.60 crore in December 2021.Quarterly Net Profit at Rs. 324.60 crore in December 2022 down 4.84% from Rs. 341.10 crore in December 2021.EBITDA stands at Rs. 726.50 crore in December 2022 up 7.31% from Rs. 677.00 crore in December 2021.Dr Reddys Labs EPS has decreased to Rs. 19.54 in December 2022 from Rs. 20.55 in December 2021.Dr Reddys Labs shares closed at 4,252.75 on January 24, 2023 (NSE) and has given -1.80% returns over the last 6 months and -3.41% over the last 12 months.",Dr. Reddy's Laboratories Ltd.
"  January 25, 2023 / 05:45 PM IST  ",Dr Reddy’s reports 77% growth in Q3 consolidated profit,"Pharma major Dr Reddy's Laboratories on January 25 reported a 77 percent growth in consolidated net profit at Rs 1,247 crore for the quarter ended December 31, 2022 as against Rs 707 crore a year ago. On a sequential basis, the profit grew 12 percent.The Hyderabad-based drugmaker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period, while it was up 7 percent sequentially.""Our strong financial performance was supported by growth in the US and the Russia markets. We continue to strengthen our development pipeline to reach more patients globally,"" Co-chairman & MD, G V Prasad, commented on its performance.ALSO READ: Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidateEBITDA for the quarter stood at Rs 1,966 crore in December 2022 - up 55 percent - as against Rs 1,266 crore in the previous corresponding quarter. EBITDA margin expanded 520 bps Y-o-Y to 29 percent, while it contracted 160 basis points sequentially.The gross margins for the quarter at 59.2 percent were 540 basis points higher from 53.8 percent a year ago. The gross margin in the quarter ended September 2022 stood at 59.1 percent.SG&A and R&D ExpensesThe selling, general and administrative (SG&A) expenses for the quarter as a percentage of revenue were down to 26.6 percent from 29.0 percent in the year-ago period and up 30bps Q-o-Q.The expenses on research and development (R&D) were down by 70bps Y-o-Y at 7.1 percent. It was at 7.7 percent in the previous quarter.Revenue mixNorth America continued to be the largest contributor to the company’s revenues with 45 percent share and was followed by emerging markets (19 percent share), India (17 percent share), PSAI (11 percent), Europe at 6 percent and others at 1 percent of the total revenue.The company generated Rs 3,060 crore of its revenue from North America, with a Y-o-Y growth of 64 percent and Q-o-Q growth of 9 percent driven by new products launches, increase in volumes and a favourable forex movement, which was partly offset by price erosion.Revenue from emerging markets at Rs 1,310 crore was up 14 percent Y-o-Y and 7 percent Q-o-Q. Within emerging markets, the yearly growth was driven by 45 percent growth in Russia, primarily owing to increase in volumes and prices, new product launches, and favorable forex rates.India, with revenues of Rs 1,130 crore, grew 10 percent year-on-year mainly led by increase in sales prices and new product launches, partly offset by reduction in volumes for certain products. The revenues were down 2 percent on a sequential basis.Europe managed to grow at 6 percent Y-o-Y and 2 percent Q-o-Q to Rs 430 crore.The Pharmaceutical Services and Active Ingredients (PSAI) business of Dr Reddy's generated revenues of Rs 780 crore for the quarter, up 7 percent Y-o-Y and 21 percent QoQ mainly owing to increase in volumes and product launches.Other highlightsThe company incurred a capex of Rs 290 crore during the quarter and generated a free cash flow of Rs 1,980 crore.The net cash surplus at the end of the quarter stood at Rs 3,400 crore.",Dr. Reddy's Laboratories Ltd.
"  January 25, 2023 / 10:17 AM IST  ",Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues,"Indian pharma major Dr Reddy’s Laboratories Limited is expected to report weak sequential earnings for the quarter ended December 2022.The company is likely to report a 18.1 percent on-quarter decline in consolidated net profit at Rs 894.2 crore for the October-December period, according to an average of estimate of brokerages polled by Moneycontrol. DRL is expected to release its earnings report on January 25.Ahead of earnings, the stock is trading lower at Rs 4185.15 apiece, down by 1.5 percent. On January 24, the stock had closed lower by 1.96 percent.US revenue is expected to decline and normalise henceforth with majority of Revlimid sales being booked in the second quarter. ICICI Securities projects the company's US revenue declining 20 percent on-quarter to $281 million, which might, however, lead to an improvement in EBITDA margin on a yearly basis.On the India business front, the drug maker expects a growth of 5 percent on-year on the back of acquired products, while the PSAI segment is expected to decline 16.3 percent during the period.“We expect North America base business (ex-Revlimid) sales to grow 4 percent on-quarter to $245 million, led by market share gains in gKuvan, steady trends in gVascepa and gSuboxone, which will offset volume declines in gCiprodex and Vasopressin AG. In our estimates, we factor in $35 million of gRevlimid sales in the US in the third quarter of FY23 for DRRD, as against $115 million in the second quarter of FY23. We expect DRRD's domestic sales to grow 6 percent YoY in 3QFY23. Owing to lower gRevlimid sales, we expect a sequential decline of 550 bps in DRRD's 3QFY23 EBITDA margin. On a YoY basis, though, we expect DRRD's EBITDA margin to improve 200 bps in 3QFY23 to 24.6 percent.”Analysts at BNP Paribas also expect the US sales to normalise around a range of $290-300 million as Dr Reddy’s benefited from the exclusivity of gRevlimid in selective dosages. They project confidence in the Russia business and expect it stabilise.Kotak Securities pegs YoY growth in Russia and Europe at 18 percent and 11 percent, respectively, in 3QFY23. “After a weak 2QFY23 due to inventory provision in Covid products as well as pricing and volume pressure in the non-Covid portfolio, we expect PSAI sales to grow 19 percent QoQ in 3QFY23. Owing to lower gRevlimid sales, we expect a sequential decline of 550 bps in DRRD's 3QFY23 EBITDA margin. On a YoY basis, though, we expect DRRD's EBITDA margin to improve 200 bps in 3QFY23 to 24.6 percent.”Overall, Revenue and EBITDA are expected to decline 6.7 percent and 24.9 percent on a quarterly basis, as per a Moneycontrol poll.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Dr. Reddy's Laboratories Ltd.
"  January 25, 2023 / 10:50 PM IST  ","INDUS TOWERS Standalone December 2022 Net Sales at Rs 6,765.00 crore, down 2.32% Y-o-Y","Net Sales at Rs 6,765.00 crore in December 2022 down 2.32% from Rs. 6,925.90 crore in December 2021.Quarterly Net Loss at Rs. 707.60 crore in December 2022 down 145% from Rs. 1,572.60 crore in December 2021.EBITDA stands at Rs. 1,252.50 crore in December 2022 down 55.15% from Rs. 2,792.60 crore in December 2021.INDUS TOWERS shares closed at 170.45 on January 24, 2023 (NSE) and has given -23.44% returns over the last 6 months and -32.77% over the last 12 months.",Indus Towers Ltd.
"  January 25, 2023 / 03:10 PM IST  ",Indus Towers shares correct 7% as 'doubtful debt provision' hits Q3 scorecard,"Shares of Indus Towers fell 7 percent on January 25 after the mobile tower installation company reported loss for third quarter of FY23 under doubtful debt provision against a telecom operator.Although the company avoided to name the telecom operator that can be blamed for delay in payment of receivables, experts believe it is Vodafone Idea that is grappling with funds crunch.Indus Towers posted a consolidated loss of Rs 708.2 crore for the quarter ended December FY23 as against a profit of Rs 1,570.8 crore a year back.""A large customer of the group accounts for substantial part of net sales for the period ended December 31, 2022 and constitutes a significant part of trade receivables and unbilled revenue as of December 2022,"" Indus Towers said its filing to exchanges.""During Q3FY23, the funding plan of the said customer has not materialised and although the committed part payment till December has been received, the customer has indicated challenges in complying with the higher payment plan in future.""Also read: Indus Towers Q3 hit by Vi's contagion, sends alarms bells ringing for investorsAccordingly, the Indus Group followed a stringent policy for making doubtful debt allowance in respect of overdue recoverable, which has resulted in additional allowance for a doubtful debt of Rs 2,298.1 crore during the December FY23 quarter, it added.Vodafone Idea is yet to announce its quarterly earnings. In September FY23 quarter, it had posted a loss of Rs 7,595.5 crore, widening from Rs 7,144.6 crore in the same period last fiscal.Indus Towers has reported a revenue of Rs 6,765 crore for the December FY23 quarter, down 2.3 percent over the last year, and its EBITDA (earnings before interest, tax, depreciation and amortisation) plunged 68 percent to Rs 1,185.8 crore from the year-ago period.EBITDA margin for the quarter at 17.5 percent dropped from 53.47 percent in the corresponding period last financial year, hit by other expenses that jumped nearly 20-fold to Rs 2,418 crore in Q3FY23.""Both adjusted revenue and EBITDA margin below estimates. Delay in collection of receivables from VIL impacting financial performance,"" Yes Securities said.The brokerage said adjusted revenue (excluding deferred revenue of Q2FY23) declined by 1.5 percent on-quarter to Rs 6,765 crore and continued to face delay in collection of receivables from VIL.On the sequential basis, EBITDA margin decreased by 1,777 bps to 17.5 percent, led by higher other expenses of Rs 2,417.8 crore (which included provision for doubtful debts of Rs 2,270.1 crore), said Yes Securities which currently has an 'add' rating on the stock.Total number of towers grew 0.8 percent sequentially and 2.5 percent annually to 1,89,392 as of December FY23, while total number of co-locations rose by 0.4 percent sequentially (1.3 percent on year) to 3,39,435.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Indus Towers Ltd.
"  January 25, 2023 / 09:25 AM IST  ","JSW Energy Standalone December 2022 Net Sales at Rs 954.69 crore, down 4.68% Y-o-Y","Net Sales at Rs 954.69 crore in December 2022 down 4.68% from Rs. 1,001.57 crore in December 2021.Quarterly Net Profit at Rs. 79.09 crore in December 2022 down 58.64% from Rs. 191.21 crore in December 2021.EBITDA stands at Rs. 249.93 crore in December 2022 down 36.6% from Rs. 394.24 crore in December 2021.JSW Energy EPS has decreased to Rs. 0.48 in December 2022 from Rs. 1.16 in December 2021.JSW Energy shares closed at 247.30 on January 24, 2023 (NSE) and has given 7.69% returns over the last 6 months and -17.90% over the last 12 months.",JSW Energy Ltd.
"  January 25, 2023 / 09:25 AM IST  ","Maruti Suzuki Standalone December 2022 Net Sales at Rs 29,044.30 crore, up 24.94% Y-o-Y","Net Sales at Rs 29,044.30 crore in December 2022 up 24.94% from Rs. 23,246.00 crore in December 2021.Quarterly Net Profit at Rs. 2,351.30 crore in December 2022 up 132.5% from Rs. 1,011.30 crore in December 2021.EBITDA stands at Rs. 3,693.90 crore in December 2022 up 95.76% from Rs. 1,887.00 crore in December 2021.Maruti Suzuki EPS has increased to Rs. 77.84 in December 2022 from Rs. 33.48 in December 2021.Maruti Suzuki shares closed at 8,698.80 on January 24, 2023 (NSE) and has given 0.90% returns over the last 6 months and 8.03% over the last 12 months.",Maruti Suzuki India Ltd.
"  January 25, 2023 / 08:26 AM IST  ",Maruti Suzuki Q3 profit zooms 130%; what should investors do now?,"Shares of Maruti Suzuki India will remain in focus on January 25, a day after the company reported its December quarter earnings.The country's largest carmaker on January 24, reported 129.55 percent jump in consolidated net profit for quarter ended December 2022 at Rs 2,391.5 crore as against Rs 1,041.8 crore in the same quarter last year.The total revenue from operations came in at Rs 29,057.5 crore, up  24.96 percent from Rs 23,253.3 crore recorded in the corresponding quarter of the previous year, Maruti Suzuki said in a stock exchange filing.Catch all the market action on our live blogHere is what brokerages have to say about stock and the company post December quarter earningsLKP ResearchThe brokerage has maintained 'Buy' rating on the stock and remains sanguine on the stock with a rolled over FY25E target of Rs 10,298.The company reported a strong margin performance in the quarter on better product mix, higher ASPs, lower input costs and higher utilization ratesWith ability to combat competition coming from EV shift and better growth in rural markets which were severely impacted by covid Wave #2, company is poised for a healthy growth here-onCLSABroking house has kept ‘Sell’ rating on the stock and raised the target price to Rs 8,240 per share as the earnings beat the estimates led by richer product mix & easing costs.The bookings remain strong aided by the new model cycle.CLSA expect company to gain market share in SUV segment on back of recent launches and believes that overall share gains will be limited over the next 2 years, reported CNBC-TV18.CitiResearch house has kept ‘Buy’ rating on the stock and raised the target price to Rs 13,100 per share.The Q3 was ahead of estimates, better pricing & improving mix aided realisations & gross margin.The management targets to gain leadership in SUV segment with 2 new models, Fronx & Jimny.Broking house raises EBIT estimates by 10-12% & earnings estimates by 9-16% over FY23-25, reported CNBC-TV18.Morgan StanleyBrokerage house has maintained ‘Overweight’ rating on the stock with a target at Rs 10,483 per share.The Q3 EBIT margin was highest in 17 quarters & above the estimates.Incrementally, expect improving mix, leverage gains & lower discount to drive earnings and expect company’s market share to rise to 43% in FY24 versus 41% in FY23 to date, reported CNBC-TV18.NomuraBrokerage house has maintained ‘Neutral’ rating on the stock with a target price of Rs 9,928.The stronger ASPs drive Q3 revenue beat, while EBITDA was margin in-line. The new SUV ramp key positive, while weaker mass segments remain a concern.The outlook is healthy and company targets ahead of industry growth & leadership in SUVs.The cost outlook is stable for Q4 and forecast margin to be stronger in Q4.The rising A&P spends, stronger JPY & regulatory costs may impact margin, reported CNBC-TV18.JefferiesResearch firm has maintained ‘Buy’ rating on the stock with a target at Rs 11,250 per share.The Q3 EBITDA was 5% above estimates led by better realisations.The company sounded positive on demand as company has 2.5 months of orderbook along with depleted channel inventories.The demand, product & margin cycles align favourably driving a quadrupling of EPS over FY22-25, reported CNBC-TV18.Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Maruti Suzuki India Ltd.
"  January 25, 2023 / 09:12 AM IST  ","Pidilite Ind Standalone December 2022 Net Sales at Rs 2,709.70 crore, up 12.14% Y-o-Y","Net Sales at Rs 2,709.70 crore in December 2022 up 12.14% from Rs. 2,416.31 crore in December 2021.Quarterly Net Profit at Rs. 296.26 crore in December 2022 down 8.14% from Rs. 322.52 crore in December 2021.EBITDA stands at Rs. 470.99 crore in December 2022 down 2.81% from Rs. 484.59 crore in December 2021.Pidilite Ind EPS has decreased to Rs. 5.83 in December 2022 from Rs. 6.35 in December 2021.Pidilite Ind shares closed at 2,382.35 on January 24, 2023 (NSE) and has given 2.10% returns over the last 6 months and -9.77% over the last 12 months.",Pidilite Industries Ltd.
"  January 25, 2023 / 09:11 AM IST  ","Pidilite Ind Consolidated December 2022 Net Sales at Rs 2,997.59 crore, up 5.15% Y-o-Y","Net Sales at Rs 2,997.59 crore in December 2022 up 5.15% from Rs. 2,850.72 crore in December 2021.Quarterly Net Profit at Rs. 304.17 crore in December 2022 down 15.15% from Rs. 358.49 crore in December 2021.EBITDA stands at Rs. 500.99 crore in December 2022 down 9.6% from Rs. 554.20 crore in December 2021.Pidilite Ind EPS has decreased to Rs. 5.98 in December 2022 from Rs. 7.05 in December 2021.Pidilite Ind shares closed at 2,382.35 on January 24, 2023 (NSE) and has given 2.10% returns over the last 6 months and -9.77% over the last 12 months.",Pidilite Industries Ltd.
"  January 25, 2023 / 06:57 AM IST  ","Trade Spotlight | What's your strategy with Poonawalla Fincorp, L&T Technology, Tata Motors on Wednesday?","The market tried to extend previous day's gains and hit a high of 18,200 on the Nifty50, but the profit booking at higher levels made the attempt fail and the index closed flat by taking support at around 18,100 or 50 DEMA (days exponential moving average) on January 24 amid caution ahead of expiry of January derivative contracts on Wednesday.The expiry of monthly contracts will take place on Wednesday, a day before the actual session. Monthly contracts usually get expired on the last Thursday of every month but this time we have a holiday on the same day due to Republic day.The BSE Sensex gained 37 points at 60,979, while the Nifty50 shed 0.20 point to 18,118.30 and formed bearish candle on the daily charts as the closing was lower than opening levels, with making higher high higher low formation for second straight session.The broader markets closed lower and the breadth remained negative for yet another session. The Nifty Midcap 100 and Smallcap 100 indices fell 0.4 percent each.Stocks that performed better than broader markets included Tata Motors which was the second biggest gainer in futures & options segment, climbing more than 3 percent to Rs 422, the highest closing level since December 6, 2022 and formed long bullish candle on the daily charts with strong volumes. The stock closed above all important long term averages (50, 100 and 200 DEMA) and got into momentum with expansion of Bollinger band. Also it has seen a breakout of downward sloping resistance trend line adjoining highs of August 17 and December 1, 2022, indicating positive mood among participants.Poonawalla Fincorp shares rallied 4 percent to Rs 302.40 and formed small bodied bullish candle on the daily charts with long upper shadow indicating profit booking at higher levels. The volume was significantly higher. It remained above all important moving averages (short and long term) and continued to take a support at Rs 285 throughout this month.L&T Technology Services was also in action, rising 3 percent to Rs 3,426 and formed bullish candle on the daily charts with upper shadow, with higher high higher low formation after forming Bullish Engulfing kind of pattern in previous session. The volume remained high for yet another session.Here's what Vaishali Parekh of Prabhudas Lilladher recommends investors should do with these stocks when the market resumes trading today:Tata MotorsThe stock after the decent correction witnessed recently has picked up well from the important support zone of Rs 375-380 levels and currently with a short consolidation phase near Rs 405-415 zone has moved past the significant 50 DEMA level of Rs 408 improving the bias.The RSI (relative strength index) once again is improving with strength indicated and can carry on the momentum still further.With a buy signal indicated, we anticipate for further rise and suggest to buy this stock for an upside target of Rs 475 levels keeping a stop-loss of Rs 395 level.Poonawalla FincorpThe stock recently had some consolidation phase maintaining above the significant 200-DMA level of Rs 285 and currently has moved past the important 50 DEMA level of Rs 297 to improve the bias. The daily chart has shown improvement in the trend with the price moving above the sloping trendline to strengthen the bias.The RSI has indicated a rise from the consolidation period and further upward move is anticipated in the coming days. With the overall chart pattern looking attractive, we suggest to buy the stock for an upside target of Rs 340, keeping a stop-loss near Rs 287.L&T Technology ServicesThe stock after the steep slide has bottomed out near Rs 3,220 zone and indicated a pullback to show signs of trend reversal and is anticipated to rise further with bias improving.The RSI has shown a decent trend reversal from the highly oversold zone to signal a buy and can carry on with the momentum in the coming days.With the risk reward looking favourable and the chart looking attractive, we suggest to buy the stock for an upside target of Rs 3,850, keeping a stop-loss of Rs 3,220.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Poonawalla Fincorp Ltd.
"  January 25, 2023 / 10:52 PM IST  ","Sona BLW Standalone December 2022 Net Sales at Rs 625.99 crore, up 42.55% Y-o-Y","Net Sales at Rs 625.99 crore in December 2022 up 42.55% from Rs. 439.14 crore in December 2021.Quarterly Net Profit at Rs. 95.59 crore in December 2022 up 25.6% from Rs. 76.11 crore in December 2021.EBITDA stands at Rs. 172.45 crore in December 2022 up 43.02% from Rs. 120.58 crore in December 2021.Sona BLW EPS has increased to Rs. 1.63 in December 2022 from Rs. 1.30 in December 2021.Sona BLW shares closed at 432.60 on January 24, 2023 (NSE) and has given -24.09% returns over the last 6 months and -33.56% over the last 12 months.",Sona BLW Precision Forgings Ltd.
"  January 25, 2023 / 10:01 AM IST  ","TVS Motor Standalone December 2022 Net Sales at Rs 6,545.42 crore, up 14.7% Y-o-Y","Net Sales at Rs 6,545.42 crore in December 2022 up 14.7% from Rs. 5,706.43 crore in December 2021.Quarterly Net Profit at Rs. 352.75 crore in December 2022 up 22.35% from Rs. 288.31 crore in December 2021.EBITDA stands at Rs. 665.42 crore in December 2022 up 15.93% from Rs. 574.00 crore in December 2021.TVS Motor EPS has increased to Rs. 7.42 in December 2022 from Rs. 6.07 in December 2021.TVS Motor shares closed at 983.85 on January 24, 2023 (NSE) and has given 12.96% returns over the last 6 months and 60.71% over the last 12 months.",TVS Motor Company Ltd.
"  January 25, 2023 / 10:01 AM IST  ","TVS Motor Consolidated December 2022 Net Sales at Rs 8,066.13 crore, up 22.26% Y-o-Y","Net Sales at Rs 8,066.13 crore in December 2022 up 22.26% from Rs. 6,597.35 crore in December 2021.Quarterly Net Profit at Rs. 300.89 crore in December 2022 up 21.45% from Rs. 247.75 crore in December 2021.EBITDA stands at Rs. 1,030.84 crore in December 2022 up 32.42% from Rs. 778.47 crore in December 2021.TVS Motor EPS has increased to Rs. 6.33 in December 2022 from Rs. 5.21 in December 2021.TVS Motor shares closed at 983.85 on January 24, 2023 (NSE) and has given 12.96% returns over the last 6 months and 60.71% over the last 12 months.",TVS Motor Company Ltd.
"  January 25, 2023 / 11:01 PM IST  ","Tata Motors Standalone December 2022 Net Sales at Rs 15,793.98 crore, up 27.86% Y-o-Y","Net Sales at Rs 15,793.98 crore in December 2022 up 27.86% from Rs. 12,352.78 crore in December 2021.Quarterly Net Profit at Rs. 506.19 crore in December 2022 up 187.85% from Rs. 175.85 crore in December 2021.EBITDA stands at Rs. 1,493.94 crore in December 2022 up 267.87% from Rs. 406.11 crore in December 2021.Tata Motors EPS has increased to Rs. 1.31 in December 2022 from Rs. 0.45 in December 2021.Tata Motors shares closed at 422.15 on January 24, 2023 (NSE) and has given -6.09% returns over the last 6 months and -11.77% over the last 12 months.",Tata Motors Ltd.
"  January 25, 2023 / 05:36 PM IST  ","Tata Motors back in black with Q3 net profit at Rs 2,958 crore; beats estimates","Tata Motors on January 25 reported a consolidated net profit of Rs 2,957.71 crore for the quarter ended December 2022, against a loss of Rs 1,516.14 crore in the same quarter last year.Revenue from operations came in at Rs 88,488.59 crore, up 22.51 percent from Rs 72,229.29 crore in the same quarter last year, Tata Motors said in an exchange filing.The Street was expecting the auto major to swing back to black with net profit estimates anywhere between Rs 300-800 crore. Consolidated sales were expected to rise over 14.5 percent year on year (YoY) and 3.9 percent sequentially to Rs 82,718 crore, estimates of analysts across four brokerages showed.ALSO READ: Tata Motors gains 6% after JLR sales vroom, CLSA upgrades stock to 'buy'Free cash flow (automotive) in the quarter, was positive at Rs 5,300 crore (as compared to Rs 4,000 crore in Q3FY22) owing to improvement in cash profits and working capital.JLRRevenue for Jaguar Land Rover (JLR), which is the biggest unit of Tata Motors, were at £6 billion, up 28 percent year on year (YoY) and up 15 percent sequentially reflecting better supplies, strong model mix and pricing.Profit before tax in the quarter was £265 million, up from a loss of £9 million a year ago with a positive EBIT margin of 3.7 percent, up from 1.4 percent in Q3FY22.The higher profitability reflects increased wholesale volumes with favourable mix, pricing and foreign exchange offset partially by higher inflation and supplier claims largely related to constrained volumes, the company said.ALSO READ: Tata Motors working on alternative fuel beyond EVs in CV spaceWholesale volumes were at 80,000, the highest level since Q1FY22 when the semiconductor shortages began and up 15 percent YoY. Liquidity remained strong at the end of the quarter with £3.9 billion of cash, it said.Commercial Vehicles (CV)Tata CV revenues were up 22.5 percent at around Rs 16,900 crore. EBITDAmargins were 8.4 percent (up 580 bps YoY) and EBIT margins were at 5.9 percent (up 650 bps YoY) led by better mix, higher realisations, costsavings and softened commodity prices.Tata CV global wholesales stood at 97,100 units (down 6 percent YoY) during the quarter, primarily because of weaker international business volumes. CV domestic wholesales were at 90,800 units (flat YoY), domestic retails at 97,700 units (up 5 percent).Passenger Vehicles (PV)Tata PV revenues were up 37 percent YoY at around Rs 11,700 crore reflecting higher volumes and realizations. EBITDA margins were 6.9 percent (up 370 bps YoY) and EBIT margins were at 1.5 percent (up 510 bps) YoY driven by improved volumes and mix, higher realizations, softening commodities and certain one offs.PV domestic wholesales were at 1,31,300 units (up 33 percent), domestic retails at 1,38,900 units (up 27 percent), which was the highest.  Q3 electric vehicle (EV) volumes were also highest at 12,600 units (up 116 percent).OutlookTata Motors said it remains cautiously optimistic on the demand situation despite global uncertainties.""We will remain vigilant on demand and our continued focus on profitable growth, improving semiconductor supplies and stable commodity prices will aid revenue growth, margin improvement and positive cash delivery in Q4FY23,"" it said.",Tata Motors Ltd.
"  January 25, 2023 / 10:21 AM IST  ","Q3 Preview: Tata Motors to be back in black, revenue to grow 14%","Tata Motors will report its October-December 2022 quarter numbers on January 25 after market hours and the Street is expecting the auto major to swing back to black with net profit estimates anywhere between Rs 300-800 crore.The company had reported a loss of Rs 1,516 crore in Q3FY22, and a loss of Rs 945 crore a quarter ago. This indicates the company is expected to post profit after recording losses for seven consecutive quarters. The last time Tata Motors posted a quarterly profit was in October-December 2020.Follow our live blog for all the market actionConsolidated sales are expected to rise over 14.5 percent year on year (YoY) and 3.9 percent sequentially to Rs 82,718 crore, estimates of analysts across four brokerages show.Apart from a low base effect, the improvement in earnings will largely be driven by strong growth in domestic passenger vehicle and commercial vehicle sales. For the month of December 2022, the company had reported a 10 percent increase in total domestic sales at 72,997 units.Passenger vehicle sales in the domestic market stood at 40,043 units as against 35,299 units in December 2021, a growth of 13.4 percent.Also Read: Maruti Suzuki Q3 profit zooms 130%; what should investors do now?Analysts believe Jaguar Land Rover's volumes will also grow on a yearly basis due to easing chip shortage issue. A report by Kotak Institutional Equities states, ""We expect JLR volumes (excluding China JV) to increase by 4 percent sequentially, led by improvement in chip availability.""""Overall, we expect revenues (ex-China JV) to increase by 6 percent QoQ, mainly due to higher mix of Range Rover,"" it added.It expects EBITDA (earnings before interest, taxes, depreciation, amortization) margin to improve to 5.2 percent in Q3 FY23 from 4.4 percent in Q2 FY23.""Margins will see an uptick driven by benefits of RM (raw material) cost moderation, along with benefits of favorable FX,"" as per Motilal Oswal Financial Services.In terms of management commentary, the Street will be keenly monitoring JLR demand outlook in Europe and China, improvement in semiconductor issues, update on acquisition of Ford's Sanand plant and electric vehicle sales.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​​​​​​​​​​​​",Tata Motors Ltd.
"  January 25, 2023 / 06:57 AM IST  ","Trade Spotlight | What's your strategy with Poonawalla Fincorp, L&T Technology, Tata Motors on Wednesday?","The market tried to extend previous day's gains and hit a high of 18,200 on the Nifty50, but the profit booking at higher levels made the attempt fail and the index closed flat by taking support at around 18,100 or 50 DEMA (days exponential moving average) on January 24 amid caution ahead of expiry of January derivative contracts on Wednesday.The expiry of monthly contracts will take place on Wednesday, a day before the actual session. Monthly contracts usually get expired on the last Thursday of every month but this time we have a holiday on the same day due to Republic day.The BSE Sensex gained 37 points at 60,979, while the Nifty50 shed 0.20 point to 18,118.30 and formed bearish candle on the daily charts as the closing was lower than opening levels, with making higher high higher low formation for second straight session.The broader markets closed lower and the breadth remained negative for yet another session. The Nifty Midcap 100 and Smallcap 100 indices fell 0.4 percent each.Stocks that performed better than broader markets included Tata Motors which was the second biggest gainer in futures & options segment, climbing more than 3 percent to Rs 422, the highest closing level since December 6, 2022 and formed long bullish candle on the daily charts with strong volumes. The stock closed above all important long term averages (50, 100 and 200 DEMA) and got into momentum with expansion of Bollinger band. Also it has seen a breakout of downward sloping resistance trend line adjoining highs of August 17 and December 1, 2022, indicating positive mood among participants.Poonawalla Fincorp shares rallied 4 percent to Rs 302.40 and formed small bodied bullish candle on the daily charts with long upper shadow indicating profit booking at higher levels. The volume was significantly higher. It remained above all important moving averages (short and long term) and continued to take a support at Rs 285 throughout this month.L&T Technology Services was also in action, rising 3 percent to Rs 3,426 and formed bullish candle on the daily charts with upper shadow, with higher high higher low formation after forming Bullish Engulfing kind of pattern in previous session. The volume remained high for yet another session.Here's what Vaishali Parekh of Prabhudas Lilladher recommends investors should do with these stocks when the market resumes trading today:Tata MotorsThe stock after the decent correction witnessed recently has picked up well from the important support zone of Rs 375-380 levels and currently with a short consolidation phase near Rs 405-415 zone has moved past the significant 50 DEMA level of Rs 408 improving the bias.The RSI (relative strength index) once again is improving with strength indicated and can carry on the momentum still further.With a buy signal indicated, we anticipate for further rise and suggest to buy this stock for an upside target of Rs 475 levels keeping a stop-loss of Rs 395 level.Poonawalla FincorpThe stock recently had some consolidation phase maintaining above the significant 200-DMA level of Rs 285 and currently has moved past the important 50 DEMA level of Rs 297 to improve the bias. The daily chart has shown improvement in the trend with the price moving above the sloping trendline to strengthen the bias.The RSI has indicated a rise from the consolidation period and further upward move is anticipated in the coming days. With the overall chart pattern looking attractive, we suggest to buy the stock for an upside target of Rs 340, keeping a stop-loss near Rs 287.L&T Technology ServicesThe stock after the steep slide has bottomed out near Rs 3,220 zone and indicated a pullback to show signs of trend reversal and is anticipated to rise further with bias improving.The RSI has shown a decent trend reversal from the highly oversold zone to signal a buy and can carry on with the momentum in the coming days.With the risk reward looking favourable and the chart looking attractive, we suggest to buy the stock for an upside target of Rs 3,850, keeping a stop-loss of Rs 3,220.Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Tata Motors Ltd.
"  January 25, 2023 / 10:39 PM IST  ","Torrent Pharma Standalone December 2022 Net Sales at Rs 1,857.00 crore, up 16.94% Y-o-Y","Net Sales at Rs 1,857.00 crore in December 2022 up 16.94% from Rs. 1,588.00 crore in December 2021.Quarterly Net Profit at Rs. 229.00 crore in December 2022 up 34.71% from Rs. 170.00 crore in December 2021.EBITDA stands at Rs. 600.00 crore in December 2022 up 29.31% from Rs. 464.00 crore in December 2021.Torrent Pharma EPS has decreased to Rs. 6.78 in December 2022 from Rs. 10.06 in December 2021.Torrent Pharma shares closed at 1,584.65 on January 24, 2023 (NSE) and has given 6.75% returns over the last 6 months and 1.65% over the last 12 months.",Torrent Pharmaceuticals Ltd.
"  January 25, 2023 / 05:23 PM IST  ",Accumulate UltraTech Cement; target of Rs 7643: Dolat Capital Market,"Dolat Capital Market's research report on UltraTech CementUTCEM reported revenue and volume in line, however realization/tn, EBITDA, EBITDA/tn and APAT below estimates. UTCEM posted +19.5% YoY growth in revenue to Rs155.2 bn led by +11.8% YoY in volume to 25.9 mt (+11.9% QoQ) coupled with +6.9% YoY in realization/tn to Rs6,002 (-0.2% QoQ). EBITDA/ APAT down by 3.5%/ 9.7% YoY to Rs23.4 bn/ Rs10.6 bn due to higher opex. We broadly maintain our revenue estimates for FY23E/ FY24E/ FY25E. However, we decrease our EBITDA estimates by 7.8%/ 4.8%/ 6.0% for FY23E/ FY24E/ FY25E factoring 9MFY23. Accordingly, we decrease our APAT estimates by 11.1%/ 6.6%/ 7.8% for FY23E/ FY24E/ FY25E. We expect 12.1%/ 8.6%/ 12.0% Revenue/ EBITDA/ APAT CAGR over FY22-25E led by 9.8%/ 10.1%/ 8.4% volume growth and 7.6%/ 0.0%/ 0.0% realization growth in FY23E/ FY24E/ FY25E.OutlookUTCEM, being the largest player in Indian cement industry is its biggest advantage. However, CMP leaves limited upside, thus we downgrade to Accumulate with a revised TP of Rs7,643 based on 15x consolidated FY25E EV/EBITDA.For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.UltraTech Cement - 23 -01-2023 - dolat",UltraTech Cement Ltd.
